Exploring the revolutionary PROTAC technology for EGFR degradation in cancer therapy, patent landscape, and future perspectives
Explore how natural polymeric nanobiocomposites are transforming cancer treatment through targeted drug delivery systems derived from natural materials.
Discover how nanoporous silicon is transforming cancer therapy through targeted drug delivery and proteomic signature discovery for personalized treatment approaches.
Explore how RNA nanotechnology represents the third milestone in medicine, offering targeted cancer therapy with undetectable toxicity through thermostable, tunable RNA nanoparticles.
Explore how pnictogens (Group 15 elements) evolved from historical poisons to revolutionary nanomedicines in cancer therapy and diagnostics.
Exploring how protein conformational changes influence cancer drug design, focusing on human aminopeptidase M1 (APN/CD13) inhibitors.